HomeAI · summaries
Storia in 9 fonti
Bristol Myers buys Nvidia's latest AI computing system for drug research - The Economic Times
Bristol Myers Squibb is buying Nvidia's latest AI computing system. This new system will support artificial intelligence in drug discovery and development. The company expects to cycle through many more potential drug candidates faster. AI tools are already cutting drug testing times by twenty to thirty percent. This investment drives rapidly growing computing demands across their research organization.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Bristol Myers to build ‘powerful’ AI factory; Samsung Biologics bids for peptide maker
Bristol Myers is the third pharmaceutical company to recently seek Nvidia’s help building a large AI data center. Elsewhere, a Novartis kidney drug gained a leg up on competitors.
- ·
statnews.com
Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputer
Bristol Myers Squibb is the third drugmaker in nine months to announce it is building the largest AI supercomputer in the life sciences industry.
